Business Wire

NICECACTUS/GLORY4GAMERS

26.2.2020 14:02:11 CET | Business Wire | Press release

Share
Nicecactus Announces the Acquisition of Glory4Gamers, European Pioneer in Tournament Organization, to Strengthen Its All-in-One Platform and Accelerate Its B2B Development

Following the announcement of an initial funding round of €5 million at the end of 2019, Nicecactus has taken yet another step forward in its global development by acquiring Glory4Gamers. The strategic alliance of these two esports experts provides 1 million users with an all-in-one solution, combining knowledge in training and skill development as well as in organizing both online and offline tournaments. Players, partners and B2B customers alike can now benefit from the comprehensive range of services of these two stakeholders.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200226005081/en/

Since the end of January 2020, Nicecactus and Glory4Gamers have combined their expertise and solutions with the ambition to further expand internationally. The G4G teams have joined the Nicecactus family to form a 70-person team. They are reinforcing the already successful model of tournaments and competitions with prize money for players of all levels. In addition, the offline B2B event package, which enables brands (sponsors and publishers) to run promotional campaigns among qualified audiences, will be developed to become one of the pillars of the Nicecactus offer.

An all-in-one platform for aspiring champions

Amateur or semi-professional players, members of the Glory4Gamers and nicecactus.gg platforms, will now benefit from a complete solution empowering them with the professional training method they need to reach their full potential and realize their dream of becoming champions. It ranges from tailor-made training sessions (tutorials and drills), to performance assessment and analysis tools, as well as daily competitions with prizes and even networking with professional players in the sector (sponsors, teams) for the most talented of them.

All players are also eligible for the Nicecactus Grassroots Esports Fund, a $1 million grant program, through which they can cover travel and accommodation expenses to participate in bootcamps at professional training locations or tournaments they have qualified for.

“The decision to acquire Glory4Gamers fits perfectly with our strategy to develop and strengthen our unique offer, which encompasses virtually all aspects of esports, from amateurs to semi-professional players, as well as companies wishing to address this highly qualified target audience,” explains Mike Hessabi, Founder & President of Nicecactus.

"The esports market is growing at breakneck speed, and we want more than ever to be at the heart of this ecosystem. Nicecactus approaches esports with an innovative vision and great ambitions. The combination of Glory4Gamers and Nicecactus felt obvious to us, as we have a very aligned vision and complementary skills," adds Cyril Chomette, CEO and Founder of Glory4Gamers.

About Nicecactus:

First ever all-encompassing esports platform, Nicecactus took root in the sun-bathed French Riviera. Its goal is to foster aspiring esports players who wish to unleash their gaming potential and master their game. Nicecactus provides them with a professional training method as well as all the tools they need to fulfill their dream of becoming champions. Players from all over the world are encouraged to give the best out of themselves, through a continued training program, a fined-tuned stats tracking system and the opportunity to compete in tournaments and make some cash out of their passion in a challenging and fun way. Its first-of-its-kind Nicecactus Grassroots Esports Fund rewards the best players for their talent and dedication by connecting them to the professional world. www.nicecactus.gg

About Glory4Gamers:

Founded in 2012, Glory4Gamers is a pioneer in amateur esports. Now the leading organizer of esports tournaments in France and 3rd in Europe, the platform holds more than 2,000 tournaments per month. Through its unique real-time refereeing component, Glory4Gamers promises its users a unique esports experience, in a fun and fair play environment, and with a human support close at hand.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release

Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release

News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi

Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo

IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release

Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr

BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release

Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye